The HCM Stock Exchange (HoSE) has announced the latest update to the blue-chip VN30 Index for July 2019, which will take officially effect from August 5.
On the Hồ Chí Minh Stock Exchange, the VN-Index edged down 0.33 per cent to close Friday at 975.40 points.
Vietnamese pharmaceutical companies are optimistic about the business prospects of the sector, with nearly 80 per cent of firms anticipating an annual industry growth rate of more than 10 per cent.
Japan’s Taisho Pharmaceutical Co Ltd will continue attempting to purchase the Hậu Giang Pharmaceutical JSC’s stakes after the Vietnamese company lifted the cap on foreign ownership to 100 per cent.
Shares advanced on Thursday on the two national stock exchanges, propped up by foreign purchases and the information that Việt Nam’s stock market was added into the FTSE Russel’s watch list for a possible market status upgrade.
The Hậu Giang Pharmaceutical Joint Stock Company (DHG) is expected to attain post-tax profit of VNĐ705 billion in 2018, up 10 per cent year-on-year, Bảo Việt Securities Company (BVSC) forecasts.
The 13th International Exhibition on Products and Supplies for Medical, Pharmaceutical, Hospital and Rehabilitation (Pharmed and Healthcare Viet Nam 2018) will be held next month in HCM City.